During the past decade, The Center for Gastrointestinal Disorders conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center for Gastrointestinal Disorders" #1 sponsor was "Celgene" with 3 trials, followed by "Evoke Pharma" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Altheus Therapeutics, Inc." with 1 trials sponsored and "Coronado Biosciences, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

According to Clinical.Site data, the most researched conditions in "The Center for Gastrointestinal Disorders" are "Crohn Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Chronic Idiopathic Constipation" (2 trials), "Colorectal Cancer" (2 trials) and "Diabetic Gastroparesis" (2 trials). Many other conditions were trialed in "The Center for Gastrointestinal Disorders" in a lesser frequency.

Most popular intervention types in "The Center for Gastrointestinal Disorders" are "Drug" (12 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "Elobixibat 10 mg" (2 trials), "Metoclopramide Nasal Spray" (2 trials) and "Placebo Nasal Spray" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Gastrointestinal Disorders" are 14 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Center for Gastrointestinal Disorders". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Center for Gastrointestinal Disorders, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Gastrointestinal Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".